TY - JOUR
T1 - Complement-Fixing Abilities and IgG Subclasses of Autoantibodies in Epidermolysis Bullosa Acquisita
AU - Cho, Heun Jung
AU - Lee, Il Joo
AU - Kim, Soo Chan
PY - 1998
Y1 - 1998
N2 - Epidermolysis bullosa acquisita (EBA) is an autoimmune-mediated subepidermal bullous disease in which the target of the autoantibodies is type VII collagen, a major component of anchoring fibrils. The purpose of this study was to evaluate the complement-fixing abilities and IgG subclass distribution of autoantibodies in EBA, and to also attempt to investigate the relation between inflammation, complement fixation and IgG subclass distribution in EBA patients. Only 2 sera of 18 patients (11%) showed weak complement-fixing abilities. IgG1 and IgG4 were the most frequently and intensely stained IgG subclasses in EBA sera. We could not find any relationship between the clinico-pathologic types, complement-fixing abilities and IgG subclasses in EBA. These results suggested that complement activation may not be a key factor of bulla formation in EBA.
AB - Epidermolysis bullosa acquisita (EBA) is an autoimmune-mediated subepidermal bullous disease in which the target of the autoantibodies is type VII collagen, a major component of anchoring fibrils. The purpose of this study was to evaluate the complement-fixing abilities and IgG subclass distribution of autoantibodies in EBA, and to also attempt to investigate the relation between inflammation, complement fixation and IgG subclass distribution in EBA patients. Only 2 sera of 18 patients (11%) showed weak complement-fixing abilities. IgG1 and IgG4 were the most frequently and intensely stained IgG subclasses in EBA sera. We could not find any relationship between the clinico-pathologic types, complement-fixing abilities and IgG subclasses in EBA. These results suggested that complement activation may not be a key factor of bulla formation in EBA.
UR - http://www.scopus.com/inward/record.url?scp=0032133031&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032133031&partnerID=8YFLogxK
U2 - 10.3349/ymj.1998.39.4.339
DO - 10.3349/ymj.1998.39.4.339
M3 - Article
C2 - 9752800
AN - SCOPUS:0032133031
SN - 0513-5796
VL - 39
SP - 339
EP - 344
JO - Yonsei medical journal
JF - Yonsei medical journal
IS - 4
ER -